MedPal AI - GLP-1s move from weight loss to heart health, widening New Health's market
Each new proven benefit is bringing a new population of patients into Mounjaro’s addressable market.
MedPal AI - second GLP-1 pill approval in two months feeds New Health
This is an area upon which MedPal has been focussed recently, launching its dedicated weight-loss website New Health.
MedPal AI - zero to £8.6m in nine months after a record July
MedPal’s annualised recurring revenue run rate stands at £8.6 million based on the July figures. All revenues are predictable, quality, recurring streams of income.
MedPal AI - acquisition of Solid State Technologies - the missing piece of MedPal's Health OS
eMARx is a profitable business which provides a digital system of record for medication administration in care homes.
MedPal AI - raises £5 million to accelerate new opportunities
MedPal raises £5 million for a complementary acquisition and expansion in the weight-loss tablet market.